Author

B. T. Berger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:deep learning· 1 Assay:proteomics· 1

Frequent Co-Authors

A. C. Joerger· 2 shared L. M. Berger· 2 shared S. Knapp· 2 shared T. Hanke· 2 shared A. Kraemer· 1 shared A. Poso· 1 shared C. Lenz· 1 shared C. Schreiber· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

A. C. Joerger

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Back-pocket optimization of 2-aminopyrimidine-based macrocycles leads to potent dual EPHA2/GAK kinase inhibitors with antiviral activity

J. Gerninghaus, R. Zhubi, A. Kraemer, M. Karim, D. H. N. Tran, A. C. Joerger, C. Schreiber, L. M. Berger, B. T. Berger, T. A. L. Ehret, L. Elson, C. Lenz, K. Saxena, S. Mueller, S. Einav, , T. Hanke

The paper optimizes a 2-aminopyrimidine-based macrocycle to create a dual EPHA2/GAK kinase inhibitor with antiviral activity against dengue virus.

bioRxiv · Feb 18, 2024 · PreprintBiochemistry

Structure-based design of selective salt-inducible kinase (SIK) inhibitors

R. Tesch, M. Rak, M. Raab, L. M. Berger, T. Kronenberger, A. C. Joerger, B. T. Berger, I. Abdi, T. Hanke, A. Poso, K. Strebhardt, M. Sanhaji, S. Knapp

This study designs a selective SIK inhibitor, MRIA9, based on a PAK inhibitor, showing its dual activity and potential for combination therapy in ovarian cancer.

bioRxiv · Apr 8, 2021 · PreprintBiochemistry